Related Experiment Video
Updated: May 6, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025)
Jose Angel Garcia-Saenz1, Isabel Blancas Lopez-Barajas2, Isabel Echavarria3
1Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain. jgsaenz@salud.madrid.org.
Abstract:
Advanced breast cancer represents a challenge for patients and physicians due to its dynamic genomic changes, which are associated with resistance to treatments. The main goals of treatment in advanced breast cancer are to improve patient quality of life and to increase patient survival. This is achieved using the most appropriate sequence of treatments based on knowledge of the natural history of the disease. In these guidelines (updated in 2025), we summarize current evidence and available therapies for the medical management of advanced breast cancer.
Insights
Advanced breast cancer presents treatment challenges due to genomic changes. These 2025 guidelines offer updated evidence and therapies to improve quality of life and survival for patients with advanced breast cancer.
Area of Science:
- Oncology
- Genomics
- Medical Treatment
Background:
- Advanced breast cancer is characterized by dynamic genomic alterations.
- These genomic changes contribute to treatment resistance.
- Effective management requires understanding the disease's natural history.
Purpose of the Study:
- To summarize current evidence for advanced breast cancer management.
- To outline available therapies for medical treatment.
- To provide updated guidelines for 2025.
Main Methods:
- Review of current scientific evidence.
- Analysis of available therapeutic options.
- Synthesis of data for guideline development.
Main Results:
- Identification of key genomic drivers in treatment resistance.
- Evaluation of treatment efficacy and sequencing strategies.
- Compilation of updated therapeutic recommendations.
Conclusions:
- Personalized treatment sequencing is crucial for advanced breast cancer.
- Continuous updates in evidence are necessary for optimal patient outcomes.
- These guidelines aim to enhance patient survival and quality of life.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Standards of Care I
Standards of Care II
Cancer Survival Analysis

